Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Incyte Corporation
M.D. Anderson Cancer Center
Incyte Corporation
Incyte Corporation
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Stanford University
Novo Nordisk A/S
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fujifilm Pharmaceuticals U.S.A., Inc.
BerGenBio ASA
Astellas Pharma Inc
Celgene
M.D. Anderson Cancer Center
Astex Pharmaceuticals, Inc.
Ono Pharmaceutical Co. Ltd
IGF Oncology, LLC
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sumitomo Pharma America, Inc.
M.D. Anderson Cancer Center
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
University of Washington
Fate Therapeutics
GlaxoSmithKline
Memorial Sloan Kettering Cancer Center
GT Biopharma, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation
M.D. Anderson Cancer Center
Gamida Cell ltd
M.D. Anderson Cancer Center
Fox Chase Cancer Center
Novartis
H. Lee Moffitt Cancer Center and Research Institute
Duke University
Gamida Cell ltd
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Novartis
National Institutes of Health Clinical Center (CC)